Hideyo Miyato
Shimotsuke, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort study.
Journal: Surgical oncology
Published: January 11, 2026
Intraperitoneal Paclitaxel-Induced Eosinophil Recruitment as a Potential Mediator of Tumor Response in Peritoneal Metastases from Gastric Cancer.
Journal: Annals of surgical oncology
Published: November 07, 2025
The in vitro acquisition of CD11a by gastric cancer cells after contact with T cells via trogocytosis increases adhesion to endothelial cells.
Journal: Experimental cell research
Published: August 06, 2025
Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus.
Journal: Journal of gastrointestinal oncology
Published: June 12, 2025
Resectable Pancreatic Adenocarcinomas following Neoadjuvant Chemotherapy with Gemcitabine Plus S-1: Two Case Reports of Opposite Oncological Outcomes.
Journal: Surgical case reports
Published: March 17, 2025
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study.
Journal: Annals of gastroenterological surgery
Published: December 21, 2024
Expression of Claudin18.2 in metastatic lesions in peritoneum of gastric cancer.
Journal: Journal of gastrointestinal oncology
Published: September 26, 2024
Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration.
Journal: Cancers
Published: July 09, 2024
Intraperitoneal Transfer of miR-29b Containing Exosome Suppresses the Development of Peritoneal Metastases from Gastric Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 02, 2024
Last Updated: 09/26/2026